Effects of Fatty Acid Supplementation on Substance Dependent Individuals

NCT00312455 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Substance-related Disorders

Interventions

DRUG: Pro-eicosapentaenoic acid (EPA)
DRUG: Pro-docosapentaenoic acid (DPA)
DRUG: Placebo

Sponsor

National Institute on Drug Abuse (NIDA)